Luzitin’s patent linked to the development of new compounds to improve the efficiency of photodynamic therapy in the treatment os cancer was distinguished with the INVENTA award in the health area. It was additionally considered the most prominent Portuguese invention of the last decade, having been considered the absolute winner […]

A new spin-off of the University of Coimbra, Luzitin, will lead the development of a safer and more effective drug using photodynamic therapy for the treatment of cancer, according to the licensing and funding agreements signed yesterday. These two agreements were celebrated between the University of Coimbra, pharmaceutical company Bluepharma, Luzitin […]